Pharmaceutical counterfeiting and analytical authentication

Current Pharmaceutical Analysis

Volumn 7, Issue 1, 2011, Pages 54-61

  Talati, Ram ^a   Parikh, Saumil ^a   Agrawal, Y K ^a  

^a GUJARAT FORENSIC SCIENCES UNIVERSITY   (India)

Author keywords

Analytical techniques; Anti counterfeiting; Counterfeit medicine; Counterfeiting

Indexed keywords

ATORVASTATIN; GLIBENCLAMIDE; INSULIN; METAKELFIN; OLANZAPINE; SILDENAFIL; TETRAHYDROLIPSTATIN;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; BIPOLAR DISORDER; BULK DENSITY; CARBON NUCLEAR MAGNETIC RESONANCE; COLORIMETRY; DRUG MANUFACTURE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFECTION CONTROL; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEAR INFRARED SPECTROSCOPY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; QUANTITATIVE ANALYSIS; RAMAN SPECTROMETRY; REFRACTION INDEX; SCHIZOPHRENIA; THIN LAYER CHROMATOGRAPHY; X RAY DIFFRACTION;

EID: 79952768192     PISSN: 15734129     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341211794708712     Document Type: Article

References (52)

1. th session, Provisional agenda item 4.11. 2008, pp. 1-3.
2. Medicines: Counterfeit medicines. WHO fact sheet no: 275. Available at: http://www.who.int/mediacentre/factsheets/fs275/en/ (Accessed June 25, 2010).
3. Seizure statistics: Fiscal year 2009. Intellectual property rights, U.S. customs and border protection, 2009, pp. 2-9.
4. Magnitude of counterfeiting and piracy of tangible products, an update. OECD: Paris, 2009, pp. 1-3.
5. Pamela W. Focus on Africa magazine, Africa - 'dumping ground' for counterfeit goods. BBC World Service. Available at: http://news.bbc.co.uk/2/hi/africa/8424403.stm (Accessed June 24, 2010).
6. Everts S. Fake pharmaceuticals, science & technology, chemical engineering news, Vol. 88(1), pp. 27-29. Available at: http://pubs.acs.org/cen/science/88/8801sci1.html (Accessed June 24, 2010).
7. Impact of counterfeiting on government and consumer, a report commission by BASCAP: An executive summery, Frontier economics Ltd: London, 2009.
8. Forzley M. Counterfeiting goods and the public's health safety, International intellectual property institute. 2003, pp. 33, 36-40. Available at: www.iipi.org
9. http://www.wipo.int/enforcement/en/faq/counterfeiting/faq04.html (Accessed 13 May, 2010).
10. Anti counterfeiting Operations, Underwriters Laboratories Inc. 2010. Available at: http: //www.ul.com/global/eng/pages/offerings/ services/programs/anticounterfeitingoperations/counterfeiting (Accessed 13 May, 2010).
11. Morris, J.; Stevens Philip D. Counterfeit medicines in less developed countries. Problems and solutions. International policy network: London, 2006, pp. 5-6.
12. Clock A. Pharmaceutical counterfeiting a global healthcare menace: A new technology tool, XStream Systems Inc.; pp. 2-3.
13. Newton, P.; Proux, S.; Green, M.; Smithius, F.; Phu, N.; Rozen-daal, J.; Prakongpan, S.; Chotivanich, K.; Mayxay, M.; Noslen, F.; White, N. Fake artesunate in southeast Asia. Lancet, 2001, 357, 1948-1950.
14. Green, M.; Mount, D.; Wirtz, R.; White, N. A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate. J. Pharm. Biomed. Anal, 2000, 24, 65-70.
15. Green, M.; Newton, P.; Fernandez, F.; Wirtz, R.; Nettey H. Simple low-cost strategies to rapidly identify counterfeit drugs in developing countries, in combating pharmaceutical fraud and counterfeiting, SMI conference documentation, SMI publishing: London, 2003.
16. Ioset, J.; Kaur, H. Simple field assays to check quality of current artemisinin-based antimalarial combination formulations. PLoS One, 2009, 4(9), e7270.
17. Phillips, G. World congress of pharmacy and pharmaceutical sciences: anti counterfeiting measures. Pharm. J., 2003, 271, 465.
18. Gaudiano, M.; Antoniella, E.; Bertocchi, P.; Valvo, L. Development and validation of a reversed-phase LC method for analyzing potentially counterfeit antimalarial medicines. J. Pharm. Biomed. Anal, 2006, 42, 132-135.
19. Flurer, C; Wolnik, K. Chemical profiling of pharmaceuticals by capillary electrophoresis in the determination of drug origin. J. Chromatogr. A., 1994, 674, 153-163.
20. Marini, R.; Rozet, E.; Montes, M.; Rohrbasser, C; Roht, S.; Rhème, D.; Bonnabry, P.; Schappler, J.; Veuthey, J.; Hubert, P.; Rudaz, S. Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicines. J. Pharm. Biomed. Anal, 2010, 53(5), 1278-1287.
21. Singh, S.; Prasad, B.; Savaliya, A.; Shah, R.; Gohil, V.; Kaur A. Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs. Trends Anal. Chem., 2009, 28(1), 13-28.
22. Ye, H.; Hill, J.; Kauffman, J.; Gryniewicz, C; Han, X. Detection of protein modifications and counterfeit protein pharmaceuticals using isotope tags for relative and absolute quantification and matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry: Studies of insulins. Anal Biochem., 2008, 379, 182-191.
23. Shen, H.; Carter, J.; Brereton, R.; Eckers C. Discrimination between tablet production methods using pyrolysis, gas chromatography, mass spectrometry and pattern recognition. Analyst, 2003, 128, 287-292.
24. Kuwayama, K.; Inoue, H.; Kanamori, T.; Tsujikawa, K.; Miyagu-chi, H.; Iwata, Y.; Kamo, N.; Kishi, T. Contribution of thermal desorption and liquid-liquid extraction for identification and profiling of impurities in methamphetamine by gas chromatography-mass spectrometry. Forensic Sci. Int., 2007, 171(1), 9-15.
25. Arthur, K.; Wolff, J.; Carrier, D. Analysis of betamethasone, dex-amethasone and related compounds by liquid chromatography/electrospray mass spectrometry. Rapid Commun. Mass Spectrom., 2004, 18, 678-684.
26. Decaestecker, T.; Clauwaert, K.; Van Blaer, J.; Lambert, W.; Van den, E.; Van Peteghem, C; De Leenheer, A. Adv. Mass Spectrom., 2001, 15, 377-378.
27. Waddell, R.; NicDaeid, N.; Littlejohn, D. Classification of ecstasy tablets using trace metal analysis with the application of chemo metric procedures and artificial neural networks. Analyst, 2004, 129, 235-240.
28. 34S measurements by MC-ICP-MS and confirmation by LA-MC-ICP-MS and HPLC-MC-ICP-MS. J. Anal At. Spectrom., 2008, 23, 1294-1299.
29. Beckers, D.; Riedl U. Unambiguous identification of packaged counterfeit drugs by X-ray Powder Diffraction (XRPD), PANalytical BV: Almelo, The Netherlands pp. 4-6.
30. Gonzalez, F.; Pous, R. Quality control in manufacturing process by near infrared spectroscopy. J. Pharm. Biomed. Anal, 1995, 10, 419-423.
31. Blanco, M.; Coello, J.; Iturriaga, H.; Maspoch, S.; De la Pezuela, C. Strategies for constructing the calibration set in the determination of active principles in pharmaceuticals by near infrared diffuse reflectance spectrometry. Analyst, 1997, 122, 761-765.
32. Scafi, S.; Pasquini, C. Identification of counterfeit drugs using near-infrared spectroscopy. Analyst, 2001, 126, 2218-2224.
33. Olsen, B.; Borer, M.; Perry, F.; Forbes, R. Screening for counterfeit drugs using near-infrared spectroscopy. Pharm. Technol., 2001, 62-71.
34. Lopes, M.; Claude, W. Investigation into classification/sourcing of suspect counterfeit Heptodin™ tablets by near infrared chemical imaging. Anal. Chim. Acta, 2009, 633, 149-155.
35. Skoog D.; Leary J. In: Principles of Instrumental Analysis, Raman Spectroscopy, 4th edn., Saunders: Philadelphia, 1992; pp. 252-289.
36. Swaminath G. Faking it -II: Counterfeiting and preventing counterfeiting of drugs. Indian J. Psychiatry, 2009, 51, 9-11.
37. Sulekhlecha A. Counterfeit and substandard drugs: The need for an effective and stringent regulatory control in India and other developing countries. Indian J. Pharmacol., 2007, 39(5), 255.
38. Bell, S.; Burns, D.; Dennis, A.; Matchett, L.; Speers, J. Composition profiling of seized ecstasy tablets by Raman spectroscopy. Analyst, 2000, 125, 1811-1815.
39. Ricci, C.; Nyadong, L.; Yang, F.; Fernandez, F.; Brown, C.; Newton, P.; Kazarian, S. Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate anti-malarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry. Anal. Chim. Acta, 2008, 623, 178-186.
40. TM, A Division of Molecular Isotope Technologies LLC. Available at: http://www.naturesfingerprint.com/product_authenticity.shtml. (Accessed June 25, 2010).
41. 13C content of aspirin and paracetamol. J. Pharm. Biomed. Anal., 2009, 50, 336-341.
42. Sherma, J. Analysis of counterfeit drugs by thin layer chromatography. Acta. Chromatographica, 2007, 19, 10-13.
43. Jotcham, R. Understanding and evaluating security technologies for pharmaceuticals, in combating pharmaceutical fraud and counterfeiting, SMI Conference Documentation, SMI Publishing: London, 2003.
44. Photography and Holography Available at: http: //www.hololight.net/holography.html#section1. (Accessed June 25, 2010).
45. Authentication Solution, JDS Uniphase Corporation, 2010. Available at: http://www.jdsu.com/products/authentication-solutions/ markets/pharmaceuticals.html (Accessed June 25, 2010).
46. Forcinio H. Technology advances anti counterfeiting options, Pharmaceutical Product Security. Pharma. Technol., 2002, 31.
47. Pancaldi, M. Authentifood, A new system for brand protection, Eurofins food testing news No. 24, 2007.
48. Brand protection in the supply chain: protecting products and profits with secure media solutions, Application white paper, Zebra Technologies, 2003.
49. Hendrick, E.; Frey, M.; Herz, E.; Wiesner, U. Cellulose acetate fibers with fluorescing nanoparticles for anti-counterfeiting and ph-sensing applications. Journal of Engineered Fibers and Fabrics, 2010, 5(1), 21-30.
50. A Study Report by Dhar Rajiv, Director, Indian Institute of Packing, Anti-Counterfeit Packaging Technologies, strategic need for the Indian industry, Confederation of Indian Industry, 2010; pp. 17-19, 26, 31. Available at: www.cii.in.
51. NanoInk, Inc., 2010. Available at: http://www.nanoink.net/NanoTech.htm (Accessed June 25, 2010).
52. Counterfeiting of Pharmaceutical Products - A real threat, OYSTAR Manesty, The Process and Packaging Group. Available at: www.oystar.manesty.com